Literature DB >> 15662207

Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension.

Hanspeter Brunner1, John R Cockcroft, John Deanfield, Ann Donald, Ele Ferrannini, Julian Halcox, Wolfgang Kiowski, Thomas F Lüscher, Giuseppe Mancia, Andrea Natali, James J Oliver, Achille C Pessina, Damiano Rizzoni, Gian Paolo Rossi, Antonio Salvetti, Lukas E Spieker, Stefano Taddei, David J Webb.   

Abstract

Dysfunction of the vascular endothelium is a hallmark of most conditions that are associated with atherosclerosis and is therefore held to be an early feature in atherogenesis. However, the mechanisms by which endothelial dysfunction occurs in smoking, dyslipidaemia, hyperhomocysteinaemia, diabetes mellitus, arterial hypertension, cerebrovascular diseases, coronary artery disease and heart failure are complex and heterogeneous. Recent data indicate that endothelial dysfunction is often associated with erectile dysfunction, which can precede and predict cardiovascular disease in men. This paper will provide a concise overview of the mechanisms causing endothelial dysfunction in the different cardiovascular risk factors and disease conditions, and of the impact of the intervention measures and treatments.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15662207     DOI: 10.1097/00004872-200502000-00001

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  192 in total

1.  Mesenteric arterial dysfunction in the UC Davis Type 2 Diabetes Mellitus rat model is dependent on pre-diabetic versus diabetic status and is sexually dimorphic.

Authors:  Sonali Shaligram; Farjana Akther; Md Rahatullah Razan; James L Graham; Núria Roglans; Marta Alegret; Arta Gharib Parsa; Kimber L Stanhope; Peter J Havel; Roshanak Rahimian
Journal:  Eur J Pharmacol       Date:  2020-04-19       Impact factor: 4.432

2.  Heart failure with preserved vs reduced ejection fraction following cardiac rehabilitation: impact of endothelial function.

Authors:  Seiya Tanaka; Yoshihito Sanuki; Kiyoshi Ozumi; Takashi Harada; Hiromi Tasaki
Journal:  Heart Vessels       Date:  2018-02-01       Impact factor: 2.037

Review 3.  Insulin Resistance and Atherosclerosis: Implications for Insulin-Sensitizing Agents.

Authors:  Antonino Di Pino; Ralph A DeFronzo
Journal:  Endocr Rev       Date:  2019-12-01       Impact factor: 19.871

4.  Rice bran protein hydrolysates reduce arterial stiffening, vascular remodeling and oxidative stress in rats fed a high-carbohydrate and high-fat diet.

Authors:  Ketmanee Senaphan; Weerapon Sangartit; Poungrat Pakdeechote; Veerapol Kukongviriyapan; Patchareewan Pannangpetch; Supawan Thawornchinsombut; Stephen E Greenwald; Upa Kukongviriyapan
Journal:  Eur J Nutr       Date:  2016-09-22       Impact factor: 5.614

5.  Impaired vasomotor function induced by the combination of hypertension and hypercholesterolemia.

Authors:  Hizir Kurtel; Stephen F Rodrigues; Cigdem E Yilmaz; Alper Yildirim; D Neil Granger
Journal:  J Am Soc Hypertens       Date:  2013 Jan-Feb

6.  The impact of acute high-intensity interval exercise on biomarkers of cardiovascular health in type 2 diabetes.

Authors:  Monique E Francois; Jonathan P Little
Journal:  Eur J Appl Physiol       Date:  2017-05-31       Impact factor: 3.078

Review 7.  Investigating Maternal Brain Alterations in Preeclampsia: the Need for a Multidisciplinary Effort.

Authors:  Lina Bergman; Pablo Torres-Vergara; Jeffrey Penny; Johan Wikström; Maria Nelander; Jose Leon; Mary Tolcher; James M Roberts; Anna-Karin Wikström; Carlos Escudero
Journal:  Curr Hypertens Rep       Date:  2019-08-02       Impact factor: 5.369

8.  Comparative effects of glyceryl trinitrate and amyl nitrite on pulse wave reflection and augmentation index.

Authors:  Lynn D Greig; Stephen J Leslie; Fraser W Gibb; Sherilyn Tan; David E Newby; David J Webb
Journal:  Br J Clin Pharmacol       Date:  2005-03       Impact factor: 4.335

9.  Liquiritin attenuates advanced glycation end products-induced endothelial dysfunction via RAGE/NF-κB pathway in human umbilical vein endothelial cells.

Authors:  Xiaoyi Zhang; Yu Song; Xiaolin Han; Liang Feng; Rushang Wang; Minghua Zhang; Maomao Zhu; Xiaobin Jia; Shaoying Hu
Journal:  Mol Cell Biochem       Date:  2012-11-15       Impact factor: 3.396

Review 10.  Scientific rationale for combination of a calcium channel antagonist and an HMG-CoA reductase inhibitor: a new approach to risk factor management.

Authors:  R Preston Mason
Journal:  Drugs       Date:  2008       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.